Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) was $4.64 for the day, down -5.31% from the previous closing price of $4.90. In other words, the price has decreased by -$5.31 from its previous closing price. On the day, 2.37 million shares were traded. XERS stock price reached its highest trading level at $5.02 during the session, while it also had its lowest trading level at $4.615.
Ratios:
Our analysis of XERS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.72.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.
On August 28, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $4.50.Craig Hallum initiated its Buy rating on August 28, 2023, with a $4.50 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 09 ’25 when Fairley Ricki Louise bought 56,667 shares for $4.90 per share.
Hecht Beth sold 40,000 shares of XERS for $217,244 on Mar 20 ’25. The insider now owns 1,353,510 shares after completing the transaction at $5.43 per share. On Mar 20 ’25, another insider, Hecht Beth, who serves as the Officer of the company, bought 40,000 shares for $5.14 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 743119232 and an Enterprise Value of 953430208. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.34. Its current Enterprise Value per Revenue stands at 4.284 whereas that against EBITDA is -220.039.
Stock Price History:
The Beta on a monthly basis for XERS is 0.70, which has changed by 1.2970297 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $6.07, while it has fallen to a 52-week low of $1.84. The 50-Day Moving Average of the stock is -1.26%, while the 200-Day Moving Average is calculated to be 31.30%.
Shares Statistics:
XERS traded an average of 3.24M shares per day over the past three months and 2525110 shares per day over the past ten days. A total of 156.01M shares are outstanding, with a floating share count of 145.27M. Insiders hold about 9.29% of the company’s shares, while institutions hold 44.59% stake in the company. Shares short for XERS as of 1745971200 were 17225333 with a Short Ratio of 5.31, compared to 1743379200 on 17038478. Therefore, it implies a Short% of Shares Outstanding of 17225333 and a Short% of Float of 11.1899994.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
